Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabe

Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434–439.PubMed 42.

Yurchenko V, Pushkarsky T, Li JH, Dai WW, Sherry B, Bukrinsky M: Regulation of CD147 cell surface expression: XL184 mouse involvement of the proline residue in the CD147 transmembrane domain. J Biol Chem 2005, 280:17013–17019.PubMedCrossRef 43. Boulos S, Meloni BP, Arthur PG, Majda B, Bojarski C, Knuckey NW: Evidence JQEZ5 that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 2006, 25:54–64.PubMedCrossRef 44. Zheng J, Koblinski JE, Dutson LV, Feeney YB, Clevenger CV: Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res 2008, 68:7769–7778.PubMedCrossRef 45. Kim J, Choi TG, Ding Y, Kim Y, Ha KS, Lee KH, Kang I, Ha J, Kaufman RJ, Lee J, Choe W, Kim selleck products SS: Overexpressed cyclophilin B

suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Cell Sci 2008, 121:3636–364.PubMedCrossRef 46. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV: Expression of cyclophilin B is associated progression and regulation with malignant of genes implicated in pathogenesis of breast cancer. Am J Pathol 2009,174(1):297–308.PubMedCrossRef Janus kinase (JAK) 47. Gomi S, Nakao M, Niiya F, Imamura Y, Kawano K, Nishizaka S, Hayashi A, Sobao Y, Oizumi K, Itoh K: A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumorspecific CTLs.

J Immunol 1999, 163:4994–5004.PubMed 48. Mi Z, Oliver T, Guo H, Gao C, Kuo PC: Thrombin-cleaved COOH-terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells. Cancer Res 2007, 67:4088–4097.PubMedCrossRef 49. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Rémy R, Xie ZH, Reed JC, Kroemer G: The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2- related proteins. J Exp Med 1998, 187:1261–1271.PubMedCrossRef 50. Lin DT, Lechleiter JD: Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J Biol Chem 2002, 277:31134–31141.PubMedCrossRef 51. Halestrap A: Biochemistry: A pore way to die. Nature 2005, 434:578–579.PubMedCrossRef 52. Tanveer A, Virji S, Andreeva L, Totty NF, Hsuan JJ, Ward JM, Crompton M: Involvement of cyclophilin D in the activation of a mitochondrial pore by Ca2+ and oxidant stress. Eur Biochem J 1996, 238:166–172.CrossRef 53. Eliseev RA, Malecki J, Lester T, Zhang Y, Humphrey J, Gunter TE: Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 2009, 284:9692–9699.PubMedCrossRef 54.

Comments are closed.